RACGAP1 and hepatocellular carcinoma: RACGAP1P, a pseudogene, was reported to be upregulated in hepatocellular carcinoma, leading to the overexpression of RACGAP1 by competitively binding with miR-15-5p, the latter of which could inhibit RACGAP1 expression [42].